These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 4173080)
1. Refractoriness of prostatism to hydroxyprogesterone capronate (delalutin) therapy. Weinberg SR J Urol; 1968 Jul; 100(1):57-8. PubMed ID: 4173080 [No Abstract] [Full Text] [Related]
2. [Results and considerations on several cases of prostatic hypertrophy treated with hydroxyprogesterone capronate]. Tinunin O Minerva Urol; 1969; 21(4):107-20. PubMed ID: 4192306 [No Abstract] [Full Text] [Related]
3. Evaluation of hydroxyprogesterone caproate in the treatment of benign prostatic hyperplasia. Jacobs D; Harper JM; Politano VA South Med J; 1967 Nov; 60(11):1174-6. PubMed ID: 4168673 [No Abstract] [Full Text] [Related]
4. Estrogenic management of benign prostatism, including early and poor-risk cases. 7-year experience. Roberts HJ J Am Geriatr Soc; 1966 Jul; 14(7):657-701. PubMed ID: 4160996 [No Abstract] [Full Text] [Related]
5. [Phonophoresis of hydroxyprogesterone capronate in the treatment of the patients with adenoma of the prostate complicated by dysuria]. Karpukhin VT; Sapozhnikov VV Vopr Kurortol Fizioter Lech Fiz Kult; 1981; (6):46-9. PubMed ID: 6175097 [No Abstract] [Full Text] [Related]
6. [On the treatment of prostatic adenoma with hydroxyprogesterone caronate]. Ibba AL Osp Ital Chir; 1968; 19(4):427-42. PubMed ID: 4180617 [No Abstract] [Full Text] [Related]
7. [Treatment of benign prostatic hypertrophy with progestogens including gestonorone caproate]. Nagel R; Hargenda B Hinyokika Kiyo; 1970 Sep; 16(9):423-8. PubMed ID: 4097356 [No Abstract] [Full Text] [Related]
9. [Pathogenesis and norsteroid treatment of bladder neck adenoma (prostatic hypertrophy)]. Magyarsóky F Acta Chir Acad Sci Hung; 1973 Aug; 14(3):209-22. PubMed ID: 4129777 [No Abstract] [Full Text] [Related]
10. [Animal experimental studies using 19-nor-17 alpha-hydroxyprogesterone caproate (Gestenoroncapronat) with respect to a possible therapeutic application in prostatic adenoma]. Hahn JD; Neumann F; Berswordt-Wallrabe R Urologe; 1968; 7(4):208-14. PubMed ID: 4177764 [No Abstract] [Full Text] [Related]
11. [Hormonal treatment of prostatic hypertrophy with special reference to the usefulness of gestagens]. Musierowicz A Wiad Lek; 1974 Nov; 27(22):1985-8. PubMed ID: 4140619 [No Abstract] [Full Text] [Related]
12. Effect of hydroxyprogesterone caproate on experimental benign prostatic obstruction in the mouse. Caine M; Superstine E Isr J Med Sci; 1973; 9(11):1559-64. PubMed ID: 4130461 [No Abstract] [Full Text] [Related]
14. [Studies using synthetic progestogens in drug therapy of so-called prostatic hypertrophy]. Scultéty S; Sas M; Varga B Z Urol Nephrol; 1973 Jan; 66(1):49-59. PubMed ID: 4121364 [No Abstract] [Full Text] [Related]
15. [Clinical and cysto-sphincterometric results of progestogen therapy of prostatic adenoma]. Makrigiannis D; Gaca AH Clin Ter; 1971 Jun; 57(5):399-416. PubMed ID: 4107104 [No Abstract] [Full Text] [Related]
16. [Use of rectal hydroxyprogesterone capronate phonophoresis for correction of endocrine disorders in patients with prostatic adenoma]. Grigor'eva VD; Sapozhnikov VV; Ponomarev IuT; Bobkova AS; Korobkina EG Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (6):29-32. PubMed ID: 6084361 [No Abstract] [Full Text] [Related]
17. Therapy with progestational agents in advanced benign prostatic hypertrophy. Geller J; Angrist A; Nakao K; Newman H JAMA; 1969 Nov; 210(8):1421-7. PubMed ID: 4187537 [No Abstract] [Full Text] [Related]